Renewed cervical screening: what the early results tell us

David C Currow and Sanchia Aranda
Med J Aust 2019; 211 (3): . || doi: 10.5694/mja2.50267
Published online: 5 August 2019

The renewed program delivers a more personalised program for women by applying risk stratification

An estimated 570 000 women were diagnosed with cervical cancer in 2018, and its incidence and mortality are particularly high in low and middle income countries.1 In Australia, the incidence of cervical cancer has plummeted since the national screening program was introduced in the early 1990s.2 More recently, the national human papillomavirus (HPV) vaccination program for teenage girls and boys was followed by a reduction in the proportion of women with high grade dysplasia and an increase in the age at which such pathology is detected,3 reflecting the positive health impacts of the program. The elimination of cervical cancer as a public health problem and the associated premature mortality is an exciting but realistic prospect.4

  • David C Currow1
  • Sanchia Aranda2

  • 1 Cancer Institute New South Wales, Sydney, NSW
  • 2 Cancer Council Australia, Sydney, NSW

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.